Related Articles
Arsenic induced complete remission in a refractory T-ALL patient with a distinct T-cell clonal evolution without molecular complete remission: A case report
Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia
Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non‑Hodgkin lymphoma
Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia
A phase I study of CAR‑T bridging HSCT in patients with acute CD19<sup>+</sup> relapse/refractory B‑cell leukemia